Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.02560513 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.23416955 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.23416955 |
4 | negative regulation of cell killing (GO:0031342) | 5.10624808 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.10624808 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00118520 |
7 | negative T cell selection (GO:0043383) | 4.96821581 |
8 | negative thymic T cell selection (GO:0045060) | 4.85985617 |
9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.82980084 |
10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.59161053 |
11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.59161053 |
12 | modulation by symbiont of host immune response (GO:0052553) | 4.59161053 |
13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.59161053 |
14 | modulation by symbiont of host defense response (GO:0052031) | 4.59161053 |
15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.59161053 |
16 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.54485647 |
17 | regulation of gamma-delta T cell activation (GO:0046643) | 4.46995661 |
18 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30502472 |
19 | positive thymic T cell selection (GO:0045059) | 4.17060421 |
20 | negative regulation of T cell mediated immunity (GO:0002710) | 4.16588623 |
21 | NIK/NF-kappaB signaling (GO:0038061) | 4.09657763 |
22 | positive regulation of granulocyte differentiation (GO:0030854) | 4.01995006 |
23 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.96051533 |
24 | T cell selection (GO:0045058) | 3.95257517 |
25 | thymic T cell selection (GO:0045061) | 3.90612905 |
26 | positive regulation of B cell differentiation (GO:0045579) | 3.90387487 |
27 | activated T cell proliferation (GO:0050798) | 3.87022742 |
28 | response to interleukin-15 (GO:0070672) | 3.86036169 |
29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.84781505 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.81239384 |
31 | macrophage activation involved in immune response (GO:0002281) | 3.79280693 |
32 | B cell receptor signaling pathway (GO:0050853) | 3.77526926 |
33 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.77221940 |
34 | negative regulation of interleukin-12 production (GO:0032695) | 3.76202262 |
35 | T cell migration (GO:0072678) | 3.76098925 |
36 | regulation of B cell differentiation (GO:0045577) | 3.75677809 |
37 | positive T cell selection (GO:0043368) | 3.72946897 |
38 | microglial cell activation (GO:0001774) | 3.72509434 |
39 | leukocyte aggregation (GO:0070486) | 3.67506154 |
40 | detection of molecule of bacterial origin (GO:0032490) | 3.63833674 |
41 | detection of other organism (GO:0098543) | 3.57827322 |
42 | interferon-gamma production (GO:0032609) | 3.57001721 |
43 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.51534930 |
44 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51211491 |
45 | cellular response to interleukin-15 (GO:0071350) | 3.50335035 |
46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43916637 |
47 | detection of external biotic stimulus (GO:0098581) | 3.32288664 |
48 | response to host immune response (GO:0052572) | 3.32034582 |
49 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.32034582 |
50 | regulation of regulatory T cell differentiation (GO:0045589) | 3.30321056 |
51 | detection of bacterium (GO:0016045) | 3.28404515 |
52 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.28264551 |
53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.26676430 |
54 | positive regulation of interleukin-2 production (GO:0032743) | 3.24242304 |
55 | T cell costimulation (GO:0031295) | 3.18753605 |
56 | myeloid cell activation involved in immune response (GO:0002275) | 3.18151937 |
57 | neutrophil activation involved in immune response (GO:0002283) | 3.16521298 |
58 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.15695027 |
59 | neutrophil activation (GO:0042119) | 3.15149085 |
60 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.14604258 |
61 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.14280008 |
62 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.13183067 |
63 | lymphocyte costimulation (GO:0031294) | 3.13164842 |
64 | regulation of tolerance induction (GO:0002643) | 3.12709060 |
65 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.11837416 |
66 | myeloid dendritic cell activation (GO:0001773) | 3.11511521 |
67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.10639087 |
68 | response to host (GO:0075136) | 3.10639087 |
69 | response to host defenses (GO:0052200) | 3.10639087 |
70 | neutrophil mediated immunity (GO:0002446) | 3.10512338 |
71 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.09797429 |
72 | tolerance induction (GO:0002507) | 3.09591195 |
73 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.07807692 |
74 | natural killer cell differentiation (GO:0001779) | 3.05815592 |
75 | regulation of T cell tolerance induction (GO:0002664) | 3.05069090 |
76 | T cell homeostasis (GO:0043029) | 3.04376782 |
77 | negative regulation of phagocytosis (GO:0050765) | 3.04253264 |
78 | detection of biotic stimulus (GO:0009595) | 3.03773946 |
79 | T cell receptor signaling pathway (GO:0050852) | 3.03543105 |
80 | respiratory burst (GO:0045730) | 3.03052519 |
81 | response to peptidoglycan (GO:0032494) | 3.02111466 |
82 | positive regulation of isotype switching (GO:0045830) | 3.01645828 |
83 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.01477105 |
84 | negative regulation of adaptive immune response (GO:0002820) | 3.00886282 |
85 | macrophage activation (GO:0042116) | 3.00781040 |
86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.98689703 |
87 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.98689703 |
88 | positive regulation of tolerance induction (GO:0002645) | 2.96837605 |
89 | natural killer cell activation (GO:0030101) | 2.94307057 |
90 | mast cell activation (GO:0045576) | 2.93092401 |
91 | dendritic cell migration (GO:0036336) | 2.92295352 |
92 | granulocyte activation (GO:0036230) | 2.91725871 |
93 | regulation of response to interferon-gamma (GO:0060330) | 2.88647255 |
94 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.88205468 |
95 | myeloid leukocyte mediated immunity (GO:0002444) | 2.87022846 |
96 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.85639127 |
97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.85410572 |
98 | cellular response to zinc ion (GO:0071294) | 2.85258326 |
99 | leukocyte cell-cell adhesion (GO:0007159) | 2.83240858 |
100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.83142172 |
101 | immunoglobulin mediated immune response (GO:0016064) | 2.83110200 |
102 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.81216847 |
103 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.79846166 |
104 | lymphocyte homeostasis (GO:0002260) | 2.79675955 |
105 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.79616163 |
106 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.76832106 |
107 | myeloid dendritic cell differentiation (GO:0043011) | 2.76806283 |
108 | response to type I interferon (GO:0034340) | 2.76480706 |
109 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.76400859 |
110 | type I interferon signaling pathway (GO:0060337) | 2.71318642 |
111 | cellular response to type I interferon (GO:0071357) | 2.71318642 |
112 | T cell proliferation (GO:0042098) | 2.71221170 |
113 | B cell mediated immunity (GO:0019724) | 2.68269529 |
114 | alpha-beta T cell activation (GO:0046631) | 2.67587265 |
115 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.67550055 |
116 | natural killer cell mediated immunity (GO:0002228) | 2.67550055 |
117 | V(D)J recombination (GO:0033151) | 2.67444694 |
118 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64686426 |
119 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.64285662 |
120 | regulation of hypersensitivity (GO:0002883) | 2.63973740 |
121 | B cell proliferation (GO:0042100) | 2.62579666 |
122 | cellular extravasation (GO:0045123) | 2.62130395 |
123 | negative regulation of B cell proliferation (GO:0030889) | 2.61299864 |
124 | megakaryocyte development (GO:0035855) | 2.60545005 |
125 | B cell homeostasis (GO:0001782) | 2.58693444 |
126 | response to muramyl dipeptide (GO:0032495) | 2.57044853 |
127 | regulation of RIG-I signaling pathway (GO:0039535) | 2.56230022 |
128 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.56205395 |
129 | positive regulation of interferon-alpha production (GO:0032727) | 2.56160758 |
130 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55011023 |
131 | mononuclear cell proliferation (GO:0032943) | 2.54067240 |
132 | regulation of necroptotic process (GO:0060544) | 2.53792415 |
133 | lymphocyte proliferation (GO:0046651) | 2.53522694 |
134 | response to protozoan (GO:0001562) | 2.53492409 |
135 | positive regulation of DNA recombination (GO:0045911) | 2.52170870 |
136 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.51997959 |
137 | nuclear pore complex assembly (GO:0051292) | 2.51426052 |
138 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50318587 |
139 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50318587 |
140 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.50305363 |
141 | defense response to protozoan (GO:0042832) | 2.49263239 |
142 | mature B cell differentiation (GO:0002335) | 2.48651054 |
143 | regulation of interferon-alpha production (GO:0032647) | 2.47560824 |
144 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.46666509 |
145 | T cell differentiation (GO:0030217) | 2.45971338 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.49790305 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.03686958 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.39913917 |
4 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.20762826 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.76150571 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.66151371 |
7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35734161 |
8 | MYC_22102868_ChIP-Seq_BL_Human | 3.23012982 |
9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13976331 |
10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.92873693 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.84651149 |
12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77709731 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76437694 |
14 | MYB_26560356_Chip-Seq_TH2_Human | 2.62508797 |
15 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.53598858 |
16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.50407536 |
17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.49975988 |
18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.47077841 |
19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.45068528 |
20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44727187 |
21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.41703673 |
22 | MAF_26560356_Chip-Seq_TH1_Human | 2.40507690 |
23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.38229877 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30824241 |
25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.28816254 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.26636208 |
27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23000941 |
28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22905278 |
29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22808324 |
30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.18314037 |
31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16911478 |
32 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.10220825 |
33 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06532165 |
34 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.89135849 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88636316 |
36 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.87691341 |
37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.82428825 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81457300 |
39 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76988628 |
40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.68359522 |
41 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.63138425 |
42 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62962919 |
43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.61950573 |
44 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58521065 |
45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54842574 |
46 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54695310 |
47 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54269544 |
48 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53785510 |
49 | MAF_26560356_Chip-Seq_TH2_Human | 1.51115173 |
50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.50437857 |
51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49342281 |
52 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48104856 |
53 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.47772166 |
54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.47120158 |
55 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.41919489 |
56 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.39546214 |
57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38940456 |
58 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38346616 |
59 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38324760 |
60 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36566424 |
61 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34321740 |
62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32441773 |
63 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32065013 |
64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30902116 |
65 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29391002 |
66 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.27911342 |
67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24359427 |
68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21376151 |
69 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.21151866 |
70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.19945466 |
71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16937191 |
72 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15833604 |
73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12988022 |
74 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12687374 |
75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.11675492 |
76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09040331 |
77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08946959 |
78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06368697 |
79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03451353 |
80 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03225279 |
81 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.01276285 |
82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00857430 |
83 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.00037902 |
84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99511091 |
85 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99443034 |
86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98637725 |
87 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97844800 |
88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96585483 |
89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95298309 |
90 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.94403415 |
91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93489478 |
92 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91723911 |
93 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91616053 |
94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.91420894 |
95 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90707276 |
96 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90512445 |
97 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90008661 |
98 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.89118912 |
99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.88577021 |
100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88125662 |
101 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.87856284 |
102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.85052986 |
103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.84538538 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83433502 |
105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.82019974 |
106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80527178 |
107 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.79666206 |
108 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79115957 |
109 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79109354 |
110 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.78154808 |
111 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77310471 |
112 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75429384 |
113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75087693 |
114 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74990734 |
115 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.74967847 |
116 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.74808486 |
117 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.74375674 |
118 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73701462 |
119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.72748113 |
120 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.71913020 |
121 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71584317 |
122 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71102768 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.99192087 |
2 | MP0000685_abnormal_immune_system | 3.36975080 |
3 | MP0005671_abnormal_response_to | 3.32131826 |
4 | MP0003763_abnormal_thymus_physiology | 3.27631574 |
5 | MP0001800_abnormal_humoral_immune | 3.11791627 |
6 | MP0001790_abnormal_immune_system | 2.96249618 |
7 | MP0005387_immune_system_phenotype | 2.96249618 |
8 | MP0002166_altered_tumor_susceptibility | 2.84088501 |
9 | MP0005000_abnormal_immune_tolerance | 2.70853493 |
10 | * MP0002452_abnormal_antigen_presenting | 2.68651281 |
11 | MP0002396_abnormal_hematopoietic_system | 2.66589861 |
12 | MP0009785_altered_susceptibility_to | 2.66405259 |
13 | MP0003436_decreased_susceptibility_to | 2.65723798 |
14 | * MP0002398_abnormal_bone_marrow | 2.59640339 |
15 | * MP0002420_abnormal_adaptive_immunity | 2.58980704 |
16 | * MP0002723_abnormal_immune_serum | 2.58028540 |
17 | * MP0001819_abnormal_immune_cell | 2.57382108 |
18 | MP0002006_tumorigenesis | 2.37367263 |
19 | MP0005025_abnormal_response_to | 2.36213345 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.29762807 |
21 | * MP0000716_abnormal_immune_system | 2.27810200 |
22 | MP0003303_peritoneal_inflammation | 2.24908712 |
23 | MP0002419_abnormal_innate_immunity | 2.14192975 |
24 | MP0004808_abnormal_hematopoietic_stem | 2.12264365 |
25 | MP0004381_abnormal_hair_follicle | 2.10920330 |
26 | * MP0000689_abnormal_spleen_morphology | 2.08980382 |
27 | * MP0002722_abnormal_immune_system | 2.08321200 |
28 | MP0002405_respiratory_system_inflammati | 2.06638886 |
29 | * MP0000703_abnormal_thymus_morphology | 2.04743009 |
30 | MP0003300_gastrointestinal_ulcer | 1.99044283 |
31 | * MP0002429_abnormal_blood_cell | 1.92408401 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.92231909 |
33 | MP0008057_abnormal_DNA_replication | 1.91133582 |
34 | MP0010155_abnormal_intestine_physiology | 1.90897430 |
35 | MP0005464_abnormal_platelet_physiology | 1.86587570 |
36 | MP0002138_abnormal_hepatobiliary_system | 1.82789144 |
37 | MP0004947_skin_inflammation | 1.82481645 |
38 | MP0001873_stomach_inflammation | 1.79449256 |
39 | MP0006082_CNS_inflammation | 1.77234755 |
40 | MP0008260_abnormal_autophagy | 1.76851067 |
41 | MP0001545_abnormal_hematopoietic_system | 1.75208017 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.75208017 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.73960043 |
44 | MP0009278_abnormal_bone_marrow | 1.66925568 |
45 | MP0001853_heart_inflammation | 1.65975092 |
46 | MP0004510_myositis | 1.65673619 |
47 | MP0010094_abnormal_chromosome_stability | 1.63321840 |
48 | MP0001845_abnormal_inflammatory_respons | 1.58212932 |
49 | MP0005451_abnormal_body_composition | 1.53707302 |
50 | MP0003693_abnormal_embryo_hatching | 1.46805444 |
51 | MP0005310_abnormal_salivary_gland | 1.46585322 |
52 | MP0003077_abnormal_cell_cycle | 1.44200717 |
53 | MP0005076_abnormal_cell_differentiation | 1.43938951 |
54 | MP0000490_abnormal_crypts_of | 1.40033455 |
55 | MP0010307_abnormal_tumor_latency | 1.39894035 |
56 | MP0003828_pulmonary_edema | 1.38277402 |
57 | MP0002009_preneoplasia | 1.37527730 |
58 | MP0003724_increased_susceptibility_to | 1.33436795 |
59 | MP0000569_abnormal_digit_pigmentation | 1.33010154 |
60 | MP0003866_abnormal_defecation | 1.32868635 |
61 | MP0000858_altered_metastatic_potential | 1.32860398 |
62 | MP0004883_abnormal_blood_vessel | 1.30158569 |
63 | MP0003448_altered_tumor_morphology | 1.25410371 |
64 | MP0005174_abnormal_tail_pigmentation | 1.24869114 |
65 | * MP0002019_abnormal_tumor_incidence | 1.22890775 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.22095953 |
67 | MP0001348_abnormal_lacrimal_gland | 1.20557996 |
68 | MP0003656_abnormal_erythrocyte_physiolo | 1.19612998 |
69 | MP0003111_abnormal_nucleus_morphology | 1.18790386 |
70 | MP0001533_abnormal_skeleton_physiology | 1.09822735 |
71 | MP0002933_joint_inflammation | 1.09731559 |
72 | MP0002877_abnormal_melanocyte_morpholog | 1.06319421 |
73 | MP0008469_abnormal_protein_level | 1.03141281 |
74 | MP0008007_abnormal_cellular_replicative | 1.02659660 |
75 | MP0004957_abnormal_blastocyst_morpholog | 0.94017557 |
76 | MP0005075_abnormal_melanosome_morpholog | 0.90945138 |
77 | MP0008058_abnormal_DNA_repair | 0.90671534 |
78 | MP0003787_abnormal_imprinting | 0.89647324 |
79 | MP0002132_abnormal_respiratory_system | 0.88922552 |
80 | MP0000350_abnormal_cell_proliferation | 0.88331551 |
81 | MP0003045_fibrosis | 0.86376511 |
82 | MP0005164_abnormal_response_to | 0.83482206 |
83 | MP0006054_spinal_hemorrhage | 0.81960791 |
84 | MP0000313_abnormal_cell_death | 0.80259194 |
85 | MP0002095_abnormal_skin_pigmentation | 0.79594655 |
86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78858522 |
87 | MP0003566_abnormal_cell_adhesion | 0.78572270 |
88 | MP0008877_abnormal_DNA_methylation | 0.76782769 |
89 | MP0003091_abnormal_cell_migration | 0.73673228 |
90 | MP0001851_eye_inflammation | 0.71961811 |
91 | MP0009764_decreased_sensitivity_to | 0.70653319 |
92 | MP0000015_abnormal_ear_pigmentation | 0.70322037 |
93 | MP0002998_abnormal_bone_remodeling | 0.69052665 |
94 | MP0002163_abnormal_gland_morphology | 0.67915049 |
95 | MP0001663_abnormal_digestive_system | 0.67387069 |
96 | MP0003172_abnormal_lysosome_physiology | 0.66836374 |
97 | MP0000371_diluted_coat_color | 0.66791675 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.66251689 |
99 | MP0009765_abnormal_xenobiotic_induced | 0.64379366 |
100 | MP0005058_abnormal_lysosome_morphology | 0.63390751 |
101 | MP0003943_abnormal_hepatobiliary_system | 0.63280733 |
102 | MP0005621_abnormal_cell_physiology | 0.61830286 |
103 | MP0009763_increased_sensitivity_to | 0.61325433 |
104 | MP0003183_abnormal_peptide_metabolism | 0.61308281 |
105 | MP0005023_abnormal_wound_healing | 0.61206495 |
106 | MP0004130_abnormal_muscle_cell | 0.60469971 |
107 | MP0002277_abnormal_respiratory_mucosa | 0.57682455 |
108 | MP0003690_abnormal_glial_cell | 0.57649005 |
109 | MP0001730_embryonic_growth_arrest | 0.57316664 |
110 | MP0003191_abnormal_cellular_cholesterol | 0.56177227 |
111 | MP0005166_decreased_susceptibility_to | 0.55717457 |
112 | MP0000604_amyloidosis | 0.55612107 |
113 | MP0001915_intracranial_hemorrhage | 0.54732968 |
114 | MP0008961_abnormal_basal_metabolism | 0.54017934 |
115 | MP0008004_abnormal_stomach_pH | 0.53887231 |
116 | MP0000249_abnormal_blood_vessel | 0.52138211 |
117 | MP0004484_altered_response_of | 0.51704356 |
118 | MP0000477_abnormal_intestine_morphology | 0.51577852 |
119 | MP0009115_abnormal_fat_cell | 0.51356417 |
120 | MP0000343_altered_response_to | 0.50420252 |
121 | MP0003795_abnormal_bone_structure | 0.49690023 |
122 | MP0002693_abnormal_pancreas_physiology | 0.49422337 |
123 | MP0000609_abnormal_liver_physiology | 0.46860437 |
124 | MP0002928_abnormal_bile_duct | 0.45255652 |
125 | MP0005376_homeostasis/metabolism_phenot | 0.44527073 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of T cell number (HP:0011839) | 5.01841171 |
2 | T lymphocytopenia (HP:0005403) | 4.99801880 |
3 | * Recurrent viral infections (HP:0004429) | 4.57619947 |
4 | Panhypogammaglobulinemia (HP:0003139) | 4.37494595 |
5 | Agammaglobulinemia (HP:0004432) | 4.35364979 |
6 | * Recurrent fungal infections (HP:0002841) | 4.17670479 |
7 | Eczematoid dermatitis (HP:0000976) | 4.11381703 |
8 | Recurrent bronchitis (HP:0002837) | 4.11228841 |
9 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.10480777 |
10 | Recurrent abscess formation (HP:0002722) | 4.07785945 |
11 | Thyroiditis (HP:0100646) | 4.06229349 |
12 | Abnormality of T cells (HP:0002843) | 4.05042122 |
13 | Chronic otitis media (HP:0000389) | 3.97861121 |
14 | IgM deficiency (HP:0002850) | 3.80470391 |
15 | Severe combined immunodeficiency (HP:0004430) | 3.76913105 |
16 | Recurrent bacterial skin infections (HP:0005406) | 3.76121491 |
17 | Cellulitis (HP:0100658) | 3.73060861 |
18 | B lymphocytopenia (HP:0010976) | 3.70147647 |
19 | Abnormality of B cell number (HP:0010975) | 3.70147647 |
20 | Combined immunodeficiency (HP:0005387) | 3.61690728 |
21 | Meningitis (HP:0001287) | 3.61053295 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58952097 |
23 | Myositis (HP:0100614) | 3.54364904 |
24 | Autoimmune thrombocytopenia (HP:0001973) | 3.50855372 |
25 | Abnormality of the fingertips (HP:0001211) | 3.46923074 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46382566 |
27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46382566 |
28 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.43702435 |
29 | Eosinophilia (HP:0001880) | 3.38744991 |
30 | IgG deficiency (HP:0004315) | 3.33824439 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 3.29154917 |
32 | Thrombocytosis (HP:0001894) | 3.24837347 |
33 | Abnormality of eosinophils (HP:0001879) | 3.22460777 |
34 | Abnormality of T cell physiology (HP:0011840) | 3.17191037 |
35 | Vasculitis (HP:0002633) | 3.13231416 |
36 | Leukocytosis (HP:0001974) | 3.08944605 |
37 | Inflammation of the large intestine (HP:0002037) | 3.05556650 |
38 | Gastrointestinal inflammation (HP:0004386) | 3.01355091 |
39 | Granulocytopenia (HP:0001913) | 3.00228605 |
40 | Nasal polyposis (HP:0100582) | 2.99071104 |
41 | Recurrent skin infections (HP:0001581) | 2.97897705 |
42 | Colitis (HP:0002583) | 2.93803702 |
43 | Retrobulbar optic neuritis (HP:0100654) | 2.86644673 |
44 | Optic neuritis (HP:0100653) | 2.86644673 |
45 | Stomatitis (HP:0010280) | 2.82059496 |
46 | * Papilloma (HP:0012740) | 2.77758190 |
47 | * Verrucae (HP:0200043) | 2.77758190 |
48 | Orchitis (HP:0100796) | 2.73122089 |
49 | Spontaneous hematomas (HP:0007420) | 2.69731729 |
50 | Pustule (HP:0200039) | 2.68812313 |
51 | Obstructive lung disease (HP:0006536) | 2.68428752 |
52 | Chronic obstructive pulmonary disease (HP:0006510) | 2.68428752 |
53 | Urticaria (HP:0001025) | 2.65234797 |
54 | Osteomyelitis (HP:0002754) | 2.65072240 |
55 | IgA deficiency (HP:0002720) | 2.64460031 |
56 | Chronic sinusitis (HP:0011109) | 2.61918497 |
57 | * Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.59897876 |
58 | Hypoplasia of the thymus (HP:0000778) | 2.58567560 |
59 | Lymphoma (HP:0002665) | 2.57121189 |
60 | Abnormality of the nasal mucosa (HP:0000433) | 2.56438569 |
61 | * Lymphopenia (HP:0001888) | 2.55737227 |
62 | Encephalitis (HP:0002383) | 2.52587806 |
63 | Arterial thrombosis (HP:0004420) | 2.47526491 |
64 | Pulmonary infiltrates (HP:0002113) | 2.45689581 |
65 | Chronic diarrhea (HP:0002028) | 2.45240857 |
66 | Autoimmune hemolytic anemia (HP:0001890) | 2.44228981 |
67 | Recurrent sinusitis (HP:0011108) | 2.43812136 |
68 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.41179131 |
69 | Gastrointestinal stroma tumor (HP:0100723) | 2.40875659 |
70 | Pulmonary embolism (HP:0002204) | 2.40650144 |
71 | Periodontitis (HP:0000704) | 2.39796200 |
72 | Slow saccadic eye movements (HP:0000514) | 2.38617365 |
73 | Abnormality of macrophages (HP:0004311) | 2.36773542 |
74 | Anorexia (HP:0002039) | 2.34483568 |
75 | Subacute progressive viral hepatitis (HP:0006572) | 2.32700954 |
76 | Gangrene (HP:0100758) | 2.31701597 |
77 | Increased IgE level (HP:0003212) | 2.30912086 |
78 | Amaurosis fugax (HP:0100576) | 2.30684859 |
79 | Acute hepatic failure (HP:0006554) | 2.29861504 |
80 | Gastrointestinal infarctions (HP:0005244) | 2.28988564 |
81 | Increased IgM level (HP:0003496) | 2.27296603 |
82 | Hypochromic anemia (HP:0001931) | 2.26186728 |
83 | Sepsis (HP:0100806) | 2.25576780 |
84 | Petechiae (HP:0000967) | 2.23279363 |
85 | Prolonged bleeding time (HP:0003010) | 2.22761608 |
86 | Bronchitis (HP:0012387) | 2.21974658 |
87 | Chest pain (HP:0100749) | 2.20366629 |
88 | Joint swelling (HP:0001386) | 2.19142141 |
89 | Interstitial pulmonary disease (HP:0006530) | 2.17929464 |
90 | Acute myeloid leukemia (HP:0004808) | 2.16052670 |
91 | Keratoconjunctivitis sicca (HP:0001097) | 2.15630444 |
92 | Hemoptysis (HP:0002105) | 2.14721993 |
93 | Recurrent pneumonia (HP:0006532) | 2.14645051 |
94 | Volvulus (HP:0002580) | 2.14111691 |
95 | Abnormal platelet volume (HP:0011876) | 2.12447533 |
96 | Abnormality of the pleura (HP:0002103) | 2.11342056 |
97 | Hypergammaglobulinemia (HP:0010702) | 2.10829284 |
98 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.10078321 |
99 | Skin ulcer (HP:0200042) | 2.04792272 |
100 | Gingivitis (HP:0000230) | 2.04648218 |
101 | Recurrent lower respiratory tract infections (HP:0002783) | 2.03836666 |
102 | Abnormality of the prostate (HP:0008775) | 2.02053789 |
103 | Hematochezia (HP:0002573) | 2.01850567 |
104 | Basal cell carcinoma (HP:0002671) | 2.00770479 |
105 | Stomach cancer (HP:0012126) | 1.99014362 |
106 | Gingival bleeding (HP:0000225) | 1.98949309 |
107 | Epistaxis (HP:0000421) | 1.98868772 |
108 | Keratoconjunctivitis (HP:0001096) | 1.96684353 |
109 | Papilledema (HP:0001085) | 1.96297446 |
110 | Viral hepatitis (HP:0006562) | 1.95670022 |
111 | Glomerulopathy (HP:0100820) | 1.94873870 |
112 | Fatigue (HP:0012378) | 1.93265902 |
113 | Emphysema (HP:0002097) | 1.92486035 |
114 | Hypochromic microcytic anemia (HP:0004840) | 1.91436985 |
115 | Alveolar cell carcinoma (HP:0006519) | 1.90031835 |
116 | Keratitis (HP:0000491) | 1.88740136 |
117 | Prominent nose (HP:0000448) | 1.88228691 |
118 | Myelodysplasia (HP:0002863) | 1.84710141 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.63229489 |
2 | TXK | 3.23377004 |
3 | MAP3K14 | 2.85023427 |
4 | JAK3 | 2.84122174 |
5 | MAP3K10 | 2.81065762 |
6 | STK10 | 2.60660961 |
7 | TYK2 | 2.53294689 |
8 | EEF2K | 2.30764092 |
9 | GRK6 | 2.28026629 |
10 | ZAP70 | 2.13830788 |
11 | ITK | 2.04520485 |
12 | IKBKE | 2.03880393 |
13 | PRPF4B | 1.99464216 |
14 | BTK | 1.98749832 |
15 | CDK12 | 1.89585505 |
16 | IRAK4 | 1.88621765 |
17 | TBK1 | 1.86672701 |
18 | BLK | 1.84129967 |
19 | SYK | 1.84070703 |
20 | JAK1 | 1.81368693 |
21 | IKBKB | 1.71738595 |
22 | TEC | 1.70624708 |
23 | KIT | 1.64934397 |
24 | FGFR3 | 1.59131725 |
25 | BMPR2 | 1.52329305 |
26 | MAP3K13 | 1.51836622 |
27 | FGFR4 | 1.50888356 |
28 | PKN2 | 1.50494826 |
29 | MST4 | 1.49693211 |
30 | FGR | 1.48921535 |
31 | PIM1 | 1.48040671 |
32 | LRRK2 | 1.46711627 |
33 | PIK3CG | 1.44826886 |
34 | CSF1R | 1.44654101 |
35 | LCK | 1.43362634 |
36 | CAMKK2 | 1.41980693 |
37 | CHUK | 1.41644053 |
38 | RPS6KA4 | 1.37141491 |
39 | HCK | 1.37070476 |
40 | CSK | 1.33863533 |
41 | NLK | 1.32916390 |
42 | IRAK1 | 1.25711433 |
43 | FLT3 | 1.24898229 |
44 | RIPK4 | 1.22277440 |
45 | CLK1 | 1.22068038 |
46 | NEK2 | 1.20691638 |
47 | CDK4 | 1.16885098 |
48 | CDC7 | 1.13183775 |
49 | NEK9 | 1.07071689 |
50 | CDK6 | 0.98768100 |
51 | FRK | 0.98237018 |
52 | SIK2 | 0.94966699 |
53 | LYN | 0.93756533 |
54 | SGK2 | 0.93615289 |
55 | EPHB1 | 0.93440009 |
56 | MARK3 | 0.92381539 |
57 | MAP3K1 | 0.90945928 |
58 | STK24 | 0.90070230 |
59 | YES1 | 0.89503809 |
60 | MAP3K3 | 0.84382678 |
61 | IRAK2 | 0.84337093 |
62 | TRIB3 | 0.83458065 |
63 | WNK1 | 0.83137819 |
64 | RPS6KB2 | 0.83030734 |
65 | JAK2 | 0.81740171 |
66 | SGK3 | 0.81323910 |
67 | MAP2K3 | 0.80384895 |
68 | TGFBR1 | 0.80367524 |
69 | TAOK3 | 0.79204064 |
70 | BRD4 | 0.79010081 |
71 | PRKCQ | 0.77295779 |
72 | MAP3K2 | 0.77177603 |
73 | ERN1 | 0.76306662 |
74 | ATR | 0.75365115 |
75 | ACVR1B | 0.74662999 |
76 | MAP3K8 | 0.74589745 |
77 | FES | 0.72866340 |
78 | STK3 | 0.72622535 |
79 | CDK9 | 0.72319708 |
80 | ALK | 0.71037246 |
81 | MARK2 | 0.66043389 |
82 | TGFBR2 | 0.64908900 |
83 | IRAK3 | 0.64534652 |
84 | PTK2B | 0.63716019 |
85 | CAMKK1 | 0.63677141 |
86 | PTK6 | 0.63209202 |
87 | PASK | 0.58800703 |
88 | KSR2 | 0.57761230 |
89 | MELK | 0.57264828 |
90 | TESK2 | 0.56021308 |
91 | TRPM7 | 0.55973598 |
92 | SIK3 | 0.52307446 |
93 | * STK4 | 0.51806889 |
94 | TAOK1 | 0.51382973 |
95 | MAPKAPK2 | 0.50526769 |
96 | HIPK2 | 0.49698231 |
97 | TLK1 | 0.48097332 |
98 | PIM2 | 0.47537321 |
99 | MAPK12 | 0.47474254 |
100 | MAP3K5 | 0.47242107 |
101 | RPS6KA5 | 0.45015119 |
102 | NUAK1 | 0.44511593 |
103 | SMG1 | 0.42850391 |
104 | RAF1 | 0.42614382 |
105 | FYN | 0.42541755 |
106 | RPS6KA6 | 0.40400685 |
107 | TNK2 | 0.40148941 |
108 | TTN | 0.39687866 |
109 | STK11 | 0.39168357 |
110 | MAPK7 | 0.38848495 |
111 | KSR1 | 0.38727296 |
112 | MAP3K11 | 0.38381658 |
113 | * CHEK1 | 0.38230549 |
114 | PDGFRB | 0.38125074 |
115 | MAPK11 | 0.36652227 |
116 | GRK5 | 0.36475195 |
117 | RET | 0.36130790 |
118 | AURKB | 0.34960737 |
119 | NEK6 | 0.34932596 |
120 | ATM | 0.34648619 |
121 | ABL1 | 0.34542931 |
122 | EGFR | 0.33686601 |
123 | DYRK3 | 0.33169928 |
124 | SGK223 | 0.32962538 |
125 | SGK494 | 0.32962538 |
126 | EPHA3 | 0.31139760 |
127 | MAP3K7 | 0.30256318 |
128 | TSSK6 | 0.30099521 |
129 | PDK1 | 0.29876811 |
130 | CDK7 | 0.29442259 |
131 | MATK | 0.29094261 |
132 | NME2 | 0.28450692 |
133 | RPS6KC1 | 0.28407483 |
134 | RPS6KL1 | 0.28407483 |
135 | MAPK3 | 0.28037509 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.12968703 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64357621 |
3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.48139241 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45604173 |
5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.34574971 |
6 | Measles_Homo sapiens_hsa05162 | 2.34245265 |
7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.34161581 |
8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.17842418 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.14854984 |
10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.04191771 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03329056 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.01842642 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.97831626 |
14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79594672 |
15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79415635 |
16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.70703009 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66274121 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.61501413 |
19 | DNA replication_Homo sapiens_hsa03030 | 1.59684296 |
20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57721002 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.57105124 |
22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56406281 |
23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52130792 |
24 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.45658933 |
25 | Influenza A_Homo sapiens_hsa05164 | 1.42386646 |
26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41086443 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.41005370 |
28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38885242 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.38681630 |
30 | Hepatitis B_Homo sapiens_hsa05161 | 1.37985109 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.37918802 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.34343198 |
33 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33166496 |
34 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32349331 |
35 | Base excision repair_Homo sapiens_hsa03410 | 1.30351860 |
36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29781107 |
37 | Mismatch repair_Homo sapiens_hsa03430 | 1.26181626 |
38 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.25382178 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.23476214 |
40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22949913 |
41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22011647 |
42 | Tuberculosis_Homo sapiens_hsa05152 | 1.19657455 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.17300441 |
44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.15938048 |
45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09642371 |
46 | Asthma_Homo sapiens_hsa05310 | 1.08163418 |
47 | HTLV-I infection_Homo sapiens_hsa05166 | 1.04548701 |
48 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99761070 |
49 | Pertussis_Homo sapiens_hsa05133 | 0.98842283 |
50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98119096 |
51 | Spliceosome_Homo sapiens_hsa03040 | 0.97024616 |
52 | Cell cycle_Homo sapiens_hsa04110 | 0.96851469 |
53 | Platelet activation_Homo sapiens_hsa04611 | 0.95169747 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93572849 |
55 | Homologous recombination_Homo sapiens_hsa03440 | 0.91008374 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.91003306 |
57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89754662 |
58 | Malaria_Homo sapiens_hsa05144 | 0.85881036 |
59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85745921 |
60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84686459 |
61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.84486032 |
62 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84161624 |
63 | Hepatitis C_Homo sapiens_hsa05160 | 0.83961739 |
64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80386040 |
65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79426910 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79077407 |
67 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78536148 |
68 | Salmonella infection_Homo sapiens_hsa05132 | 0.78121921 |
69 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72518605 |
70 | * Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72063134 |
71 | Phagosome_Homo sapiens_hsa04145 | 0.71444332 |
72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70941582 |
73 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.70818268 |
74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.69212506 |
75 | RNA transport_Homo sapiens_hsa03013 | 0.68354002 |
76 | Ribosome_Homo sapiens_hsa03010 | 0.66284933 |
77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64779427 |
78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61432378 |
79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.61080777 |
80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60949415 |
81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.60804661 |
82 | RNA degradation_Homo sapiens_hsa03018 | 0.58026385 |
83 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56516837 |
84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56469463 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55965505 |
86 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53203232 |
87 | Prostate cancer_Homo sapiens_hsa05215 | 0.53027521 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52898891 |
89 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52698898 |
90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52543221 |
91 | Glioma_Homo sapiens_hsa05214 | 0.52379511 |
92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51653664 |
93 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49849917 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49297163 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49162373 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47607885 |
97 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46655839 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45362746 |
99 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44919362 |
100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44247799 |
101 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43718316 |
102 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43489830 |
103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43203889 |
104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41905583 |
105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41413687 |
106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40414131 |
107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37398985 |
108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36452857 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.35564669 |
110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35408928 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35008835 |
112 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.33594490 |
113 | Endocytosis_Homo sapiens_hsa04144 | 0.33577133 |
114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.33259649 |
115 | Other glycan degradation_Homo sapiens_hsa00511 | 0.33168064 |
116 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32080420 |
117 | Adherens junction_Homo sapiens_hsa04520 | 0.31363326 |
118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31290504 |
119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30246958 |
120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29684192 |
121 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29493171 |
122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.28599445 |